Lyell Immunopharma shares owned by Vanguard Group
Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Lyell Immunopharma
Tip: Access up to 7 years of quarterly data
All positions including Lyell Immunopharma held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lyell Immunopharma by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $30M | 13M | 2.23 |
| 2023-12-31 | $26M | 14M | 1.94 |
| 2023-09-30 | $25M | 17M | 1.47 |
| 2023-06-30 | $54M | 17M | 3.18 |
| 2023-03-31 | $30M | 13M | 2.36 |
| 2022-12-31 | $44M | 13M | 3.47 |
| 2022-06-30 | $69M | 11M | 6.52 |
| 2022-03-31 | $44M | 8.8M | 5.05 |
| 2021-09-30 | $33M | 2.2M | 14.80 |
| 2021-06-30 | $29M | 1.7M | 16.36 |